Artiva Biotherapeutics, Inc To Start Trading Tomorrow

Artiva Biotherapeutics, Inc ARTV IPO will take place July, 19 on the NASDAQ exchange under the ticker ARTV.

The company is offering shares at an expected price between $14.00 and $16.00 per share with an insider lock-up period of 180 days ending on January 15, 2025.

See also: Benzinga IPO Calendar

About Artiva Biotherapeutics, Inc

Artiva Biotherapeutics, Inc is a clinical-stage biotechnology company focused on developing NK cell-based therapies for patients suffering from devastating autoimmune diseases and cancers.

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.